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Objective: Trabecular Bone Score (TBS) is an index of bone microarchitecture that provides additional
skeletal information to areal Bone Mineral Density (aBMD). Recently TBS data has been used to optimize
the Fracture Risk Assessment Tool (FRAX) predictive value. The aim of this study was to evaluate the
clinical value of TBS on FRAX algorithm.
Materials and Methods: Among total of 358 postmenopausal Iranian women (mean age 61.3 ± 9.5 years)
tested for aBMD and TBS, 184 osteopenic women were identiﬁed. Thoracolumbar spine X-ray done in all
participants revealed twenty-one vertebral fractures. For the osteopenic group, FRAX and TBS adjusted
FRAX (FRAX-TBS) were calculated and compared.
Results: Mean TBS of the patients was 1.31 (±0.11). A signiﬁcant correlation was found between TBS and
spine aBMD (r ¼ 0.50, p < 0.001) and TBS and femoral neck aBMD (r ¼ 0.37, p < 0.0001). A strong positive
correlation was observed between aBMD adjusted FRAX and FRAX-TBS in predicting the risk of major
osteoporotic fracture (r ¼ 0.90, p < 0.0001), and hip fracture (r ¼ 0.97, p < 0.0001). According to the area
under the receiver operating characteristics curve, the predictive value of the three different models
using aBMD, TBS, and combination of aBMD and TBS were similar (0.765, 0.776, and 0.781, respectively;
p ¼ 0.19). The proportion of the women needed treatment remained unchanged using FRAX or FRAX-TBS.
Conclusion: This study showed no clinical beneﬁt for TBS in postmenopausal women. Adding TBS data to
aBMD or FRAX neither improved aBMD predictive value for vertebral fracture nor changed the decision
on treatment based on FRAX.
© 2018 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Osteoporosis as a leading cause of bone fragility fractures, is a
major public health problem mostly affecting postmenopausal
women and aging individuals of both sexes [1,2]. In 1990, the
prevalence of fragility fracturewas about 1.5millionworldwide and
it is estimated to reach three millions by 2025 [3]. Osteoporotic
fragility fractures lead to severe mortality and morbidity, a signif-
icant burden on society in general, and a huge economic impact [4]., Baharestan Sq, Tehran, Iran.
bihiyeganeh).
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. No other uses without permission. COsteoporosis is a common health problem among Iranian popula-
tion, as well [5].
Considering osteoporosis as a skeletal disorder characterized by
both low bone density and microarchitectural deterioration, it
seems logic that to prevent osteoporotic fracture we need to pay
attention to the both surrogates of bone strength [6]. Until recently,
areal bone mineral density (aBMD) was the only method used in
assessment of osteoporosis and fracture risk. This approach resul-
ted in an important clinical problem: more than half of the fragility
fractures occurred in people with aBMD above the diagnostic
threshold of osteoporosis [7]. On the other hand, treating everyone
with the T-scores between 1 and 2.5 is neither medically nor
economically appropriate. Fracture risk assessment tool (FRAX) is a
supportive software in the ﬁeld of osteoporosis managementy Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
ences from ClinicalKey.com by Elsevier on September 08, 2019.
opyright ©2019. Elsevier Inc. All rights reserved.
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with low bone density who are at a higher risk of fragility fracture;
in fact it particularly provides a quantitative estimate of absolute
fracture risk to decide which osteopenic patient most likely bene-
ﬁts from treatment [8].
Trabecular bone score (TBS) is an indirect indicator of bone
microarchitecture. It is a texture measurement that quantiﬁes
local variations in gray level distribution from dual-energy X-
ray Absorptiometry (DXA) and is signiﬁcantly correlated with
three dimensional parameters of bone microarchitecture,
independently of aBMD [9e12]. Given the importance of bone
microarchitecture in the evaluation of fragility fractures, TBS
has been recently added to FRAX. Considering bone micro-
architecture in combination with aBMD and other risk factors,
TBS adjusted FRAX (FRAX-TBS) provides its users a 10-year
percentage of the risk of hip fracture (HF) and major osteopo-
rotic fracture (MOF) [13].
Here we assessed the bone microarchitecture of post-
menopausal Iranian women using TBS. We aimed to compare their
FRAX-TBS with the usual aBMD based FRAX in order to ﬁnd if
adding TBS could affect the fracture risk assessment in our
population.Materials and methods
In a cross-sectional study, a number of 358 postmenopausal
women indicated for osteoporosis screening were recruited from
Rheumatology clinic of Resalat General Hospital, Tehran, Iran. The
patients were referred to densitometry ward for aBMD and TBS
evaluation. Exclusion criteria included bisphosphonates or any
osteoporosis drugs consumption within the past two years, a his-
tory of Cushing's syndrome, malabsorption syndrome, liver failure,
creatinine clearance <30 mL/min, or any chronic disorders of
mineral metabolism. Women with type 2 diabetes were also
excluded from the study. Since type 1 diabetes is considered as
secondary osteoporosis in FRAX algorithm, we did not consider it in
our exclusion criteria. In addition, since TBS can only be computed
for patients with Body Mass Index (BMI) in range of 15e37 kg/m2,
only such postmenopausal women were included. Women were
considered postmenopausal if they had amenorrhea for more than
one year.
Thoracolumbar spine X-ray was obtained to evaluate the
vertebrate fracture using the semi quantitative approach developed
by Genant et al. [14].Dual-energy X-ray absorptiometry (DXA) and TBS
aBMD of the spine (L1-L4) and femoral neck were evaluated
using a DXA machine (Hologic Discovery). Bone mineral density
was expressed in mg/cm2 and T-score. T-score > 1,1 to 2.5 and
<2.5 was considered as normal, osteopenic and osteoporotic,
respectively.
TBS evaluation was performed along with aBMD evaluation.
Anteroposterior (AP) spine acquisitions were implemented to
evaluate TBS for L1eL4. TBS calculation was performed by TBS
iNsight software (version 2.2; Medimaps, Geneva, Switzerland).
TBS was assessed by determining the variogram of the trabecular
bone projected image, calculated as the sum of the squared gray-
level differences between pixels at a speciﬁc distance and angle.
Subsequently, TBS was computed as the slope of the logelog
transform of this variogram [12]. The average value of the indi-
vidual measurements for L1eL4 represents the lumbar spine TBS
(unit less). TBS results were classiﬁed as Degraded (<1.2), Partial
degraded (1.2e1.35), and Normal (>1.35).Downloaded for Anonymous User (n/a) at Iran University of Medical 
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Calculations of MOF and HF risk were performed using recently
released Iranian aBMD adjusted FRAX (FRAX-BMD) online software
(www.shefac.uk/FRAX). The clinical risk factors included were sex,
age, weight, previous fracture, parental hip fracture, smoking,
glucocorticoids consumption, alcohol consumption, rheumatoid
arthritis and secondary osteoporosis. National Osteoporosis Foun-
dation (NOF) cutoff values of 20% for MOF risk and 3% for HF risk
were considered as high absolute 10 years risk of fracture [15].
TBS adjusted FRAX (FRAX-TBS)
In order to evaluate the effect of TBS on vertebral fragility
fracture risk and to decide who may mostly beneﬁt from pharma-
ceutical treatment, FRAX algorithm was calculated for osteopenic
women before and after adjustment on TBS. Since osteoporotic
patients are indicated for pharmaceutical treatment regardless of
their fragility fracture risk, FRAX was not calculated for that group.
In addition, normal individual are not indicated for pharmaceutical
treatment. As a result, FRAX was not assessed for this group either.
Statistical analysis
IBM SPSS statistics version 21.0.1 (SPSS Inc., Chicago, IL, USA)
and Stata software were used for data analysis. The sample size was
estimated using sample size calculator for multiple regression
models (http://www.danielsoper.com/statcalc/calculator.aspx?
id¼1). With a statistical power of 0.80, probability level of 0.05,
and 10 predictors, the sample size was estimated almost 350.
During the study period, we recruited 358 subjects. Pearson's/
Spearman's correlation coefﬁcients were calculated to assess as-
sociation between numeric variables. Independent sample T-test or
ManneWhitney U and chi-square tests were used to assess differ-
entiation of means and percentages across groups respectively. In
order to assess means across more than two groups, Analysis of
Variance (ANOVA) was used. Comparison of the proportion of pa-
tients needing a therapeutic intervention before and after TBS
adjustment of FRAX was performed using McNemar's test. In order
to evaluate the predictive effect of aBMD and TBS adjusted with age
and BMI on vertebral fracture, binary multiple logistic regressions
was used. Finally, in order to show the fracture predictive validity of
spine aBMD (Model 1), spine TBS (Model 2) and their combination
(Model 3), adjusted for age and BMI, Receiver Operating Charac-
teristic Curve (ROC) was used. Area under the curve (AUC) was
tested using chi-square test in Stata software. Signiﬁcance level was
considered as 0.05.
Results
From a total of 358 postmenopausal Iranian women, mean age
of 61.3 ± 9.5 years, ninety-nine osteoporotic, 184 osteopenic and 75
normal women were identiﬁed. The mean spine and femoral neck
aBMDwere 882 ± 134mg/cm2, and 692 ± 114mg/cm2, respectively.
Their corresponding mean T-scores were 1.51 ± 1.21 at lumbar
spine, and 1.48 ± 0.98 at femoral neck region.
FRAX-BMD and FRAX-TBS have also been computed and the
data have been shown in Table 1.
Themean TBSwas 1.31 ± 0.11, ranging from 0.95 to 1.6. TBS value
was signiﬁcantly different across a BMD status (p < 0.0001). Post
Hoc tests demonstrated that TBS value was also signiﬁcantly
different between all possible pairs of aBMD status (p < 0.0001).
According to TBS status, the bone microarchitecture was
degraded in 45 (12.6%), partially degraded in 176 (49.1%), and
normal in 137 (38.3%) postmenopausal women.Sciences from ClinicalKey.com by Elsevier on September 08, 2019.
n. Copyright ©2019. Elsevier Inc. All rights reserved.
Table 1
Demographic and densitometric characteristics of the patients.
Variable Mean±SD
Age (year) 61.3 ± 9.5
Menopausal age (year) 48.8 ± 4.1
Height (cm) 155.3 ± 6.6
Weight (kg) 69 ± 11.6
BMI (kg/m2) 28.5 ± 4.5
L1eL4 T score 1.51 ± 1.21
Femoral neck T score 1.48 ± 0.98
L1eL4 TBS 1.31 ± 0.11
FRAX-BMD, MOF 4.3 ± 2.1
FRAX-BMD, HF 0.8 ± 0.96
FRAX-TBS, MOF 4.7 ± 2.4
FRAX-TBS, HF 0.9 ± 0.99
BMI: body mass index, TBS: trabecular bone score, aBMD: areal bone
mineral density, FRAX-BMD: BMD adjusted FRAX, FRAX-TBS: TBS
adjusted FRAX, MOF: major osteoporotic fracture, HF: hip fracture.
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(3%), 21 (28%), and 52 (69%) degraded, partially degraded and
normal TBS were identiﬁed, respectively. In the osteopenic group,
16 (9%), 100 (54%), and 68 (37%) cases showed degraded, partially
degraded and normal TBS values, respectively. From ninety-nine
osteoporotic women, 27 (27), 55 (56%), and 17 (17%) cases found
having degraded, partially degraded and normal TBS status,
respectively (Table 2).
TBS was positively correlated with spine and femoral neck
aBMD (r ¼ 0.50, p < 0.0001, and r ¼ 0.37, p < 0.0001; respectively).
Signiﬁcant negative correlation was observed between TBS and the
age of our cohort (r ¼ 0.38, p < 0.0001). Spinal and femoral neck
aBMD were also negatively correlated with age of participants
(r ¼ 0.15, p ¼ 0.003, and r ¼ 0.33, p < 0.0001, respectively).
Based on FRAX or FRAX-TBS algorithm, none of osteopenic
women hadMOF risk of more than 20%. Regarding HF, using each of
FRAX or FRAX-TBS algorithm detected the same 5 (3%) women of
the osteopenic group as high risk for HF (p ¼ 1).
Strong positive correlations were observed between FRAX-BMD
and FRAX-TBS in predicting osteoporotic fracture risks (Fig. 1).
A total of twenty-one vertebral fragility fractures were identiﬁed
in the study participants. While themajority of the fracture positive
womenwere found in the partially degraded group, two cases were
classiﬁed in the normal TBS group (Table 3). The mean TBS value of
the fracture negative women was signiﬁcantly higher than the
fracture positive cases (1.32 ± 0.11 versus 1.24 ± 0.09, respectively,
p ¼ 0.002).
While only one fracture occurred in awomanwith normal aBMD,
the majority of the other twenty fractures found in the osteoporotic
group (Table 4). The mean spine aBMD of patients without fracture
was signiﬁcantly more than patients with fracture (888 ± 131 mg/
cm2 versus 794 ± 136 mg/cm2, respectively, p ¼ 0.003).
Both aBMD and TBS were signiﬁcant predictors of vertebral
fracture after adjustment for age and BMI (p ¼ 0.008 and 0.01,
respectively) (Table 5).Table 2
Distribution of TBS status according to aBMD status of the patients.
aBMD status TBS status Total
Degraded Partially degraded Normal
Osteoporosis 27 (27) 55 (56) 17 (17) 99 (100)
Osteopenia 16 (9) 100 (54) 68 (37) 184 (100)
Normal 2 (3) 21 (28) 52 (69) 75 (100)
Total 45 (13) 176 (49) 137 (38) 358 (100)
Data denoted as number (%). TBS: trabecular bone score, aBMD: areal bone mineral
density.
Downloaded for Anonymous User (n/a) at Iran University of Medical Sci
For personal use only. No other uses without permission. CFor the patients with vertebral fracture, ROC curve was depicted
for three different age and BMI adjusted models including spine
aBMD, TBS, and combination of spine aBMD and TBS. The obtained
areas under the curve values were 0.765 (p < 0.0001), 0.776
(p < 0.0001), and 0.781 (p < 0.0001), respectively (Fig. 2). Although
a trend for better fracture prediction using combination model was
found, the difference was not signiﬁcant (p ¼ 0.19).
Discussion
TBS as an index of bone microarchitecture has been recently
included in FRAX algorithm. Adding TBS to FRAX software, as a
complementary factor of fracture prediction might be considered
as a valuable approach to optimize FRAX algorithm and lessen its
potential pitfalls [16e19].
The present study demonstrates the role of TBS in fracture risk
assessment in 358 Iranian postmenopausal women from an
outpatient clinic. Based on our ﬁndings, the proportion of patients
who needed therapeutic intervention did not change after FRAX
adjustment on TBS. It may be explained at least in part by the fact
that mean FRAX MOF and mean FRAX HF in our cases were about
4% and less than 1% respectively. Considering the frank difference of
our patients’ FRAX with the established cut points for treatment of
20% and 3% respectively, it is logically expected not to reach a
considerable change even after adjustment on TBS [6].
As a rather new point of interest in the ﬁeld of osteoporosis, the
number of studies in assessing the potential optimizing effect of TBS
on predictive value of FRAX for fracture is increasing but still there is
no consensus in this regards [20e22]. It seems that the debate is
mainly due to lack of enough convincing evidences from well-
designed studies with focus on TBS adjustment of FRAX as the pri-
mary end point. The current available data have been mainly
resulted from studies on heterogeneous population regarding age,
sex, bone microarchitecture, type of fracture assessed, and duration
of possible follow up. In a meta-analysis by McCloskey done on
17,809 men and women in fourteen prospective population-based
cohorts, TBS found to be a signiﬁcant predictor of fracture risk
independently of FRAX [13]. Unlike McCloskey's ﬁnding, we found
no positive effect from TBS adjustment of FRAX on prediction of
fracture but we should pay attention that there was only a small
increase of the prediction in the mentioned study. The primary
research question in the recent study by Couraud et al. was very
similar to our study, although it was done in an inpatient setting of
high risk patients for osteoporosis with fracture [22]. Similar to our
ﬁndings they showed that the proportion of patients at high risk of
fracture was similar using FRAX or FRAX adjusted on TBS. In a
subgroup analysis in the age category group ofmore than sixty years
old, they found a small increase in the percentage of patients needed
therapeutic intervention using FRAX-TBS. We could not perform
such a subgroup analysis because the number of fractures in our
study was not comparable to Couraud's study. Boutroy et al. in
OFFLEY study directly focused on the role of TBS on fracture pre-
diction [10]. Our study is similar to the OFFLEY in its included
postmenopausal participants and their lumbar T-score. Both studies
showed similar odds ratios of TBS or BMD in prediction of fracture,
equality of TBS and BMD in fracture risk prediction, and no added
value for combination of BMD and TBS in that regard. Our study was
different with theOFFLEY in some points: they did not use FRAX-TBS
but we did, they could follow the patients for about seven years and
could pick upmore fractures comparing to our results. Mildly higher
age of the patients at inclusion time may be another explanation for
their more fractures found. The recent publication in this ﬁeld by Su
et al. was performed on elder Chinese men and women to evaluate
the effect of TBS on FRAX [21]. Similar to our results they did not
reach any signiﬁcant beneﬁt from adding TBS to FRAX inences from ClinicalKey.com by Elsevier on September 08, 2019.
opyright ©2019. Elsevier Inc. All rights reserved.
Fig. 1. Scatter plots of the correlation between aBMD - FRAX and FRAX-TBS for prediction of (A) MOF risk (r ¼ 0.90, p < 0.0001), (B) HF risk (r ¼ 0.97, p < 0.0001). aBMD: areal bone
mineral density, FRAX: Fracture Risk Assessment Tool, TBS: trabecular bone score, MOF: major osteoporotic fracture, HF: hip fracture.
Fig. 2. Receiver operating characteristics curve analysis of different models for pre-
diction of vertebral fracture. All modes have been adjusted for age and body mass
index. Model 1: spine aBMD, Model 2: TBS, Model 3: combination of aBMD and TBS.
aBMD: areal bone mineral density, TBS: trabecular bone score * p < 0.00001.
Table 3
Distribution of fragility fractures based on TBS status of the patients.
TBS status Fracture Total
No Yes
Degraded 41 (91.1) 4 (8.9) 45 (100)
Partially degraded 161 (91.5) 15 (8.5) 176 (100)
Normal 135 (98.5) 2 (1.5) 137 (100)
Total 337 (94.1) 21 (5.9) 358 (100)
Data denoted as number (%). TBS: trabecular bone score.
Table 4
Distribution of fragility fractures based on aBMD status of the patients.
aBMD status Fracture Total
No Yes
Osteoporosis 84 (84.8) 15 (15.2) 99 (100)
Osteopenia 179 (97.3) 5 (2.7) 184 (100)
Normal 74 (98.7) 1 (1.3) 75 (100)
Total 337 (94.1) 21 (5.9) 358 (100)
Data denoted as number (%). aBMD: areal bone mineral density.
Table 5
Logistic regression analysis showing the fracture predictive values of aBMD and TBS.
Factor Odds Ratio 95% CI p value
TBS 1.58 1.27e1.76 0.003
TBS adjusted for age and BMI 1.47 1.18e1.69 0.01
aBMD 1.68 1.48e1.81 0.001
aBMD adjusted for age and BMI 1.61 1.42e1.77 0.008
aBMD: areal bone mineral density, TBS: trabecular bone score, CI: conﬁdence
interval.
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thresholds, FRAX-TBS brought about 5% overall correct reclassiﬁca-
tion for MOFs prediction than FRAX alone in Chinese men.
We could also demonstrate a signiﬁcant but moderate correla-
tion between TBS and aBMD in accordance with other studies
[10,23]. In spite of this agreement between the two models we
should pay attention to possible pitfalls of each algorithm. One of
the main well known limitations of BMD is its error in elder people
who may frequently suffer from lumbar osteoarthritis [24]. UsingDownloaded for Anonymous User (n/a) at Iran University of Medical 
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noticed that two of our patients presented with normal BMD but
fully degraded TBS. When we reviewed their proﬁles, severe
osteophytes were evident in their spines X-rays, which could
explain their false positive normal BMD. Although TBS may have
clariﬁed their real bone architecture for us, still there is a debate on
the importance of this ﬁnding in routine daily practice. In fact up to
this time there is no answer to the important clinical question on
how to manage a person with good BMD but poor TBS.
The current study carries some limitations. Having no data
registry system for osteoporotic patients prevented us from access
to reliable fracture data and their proper follow. The number of
fractures was rather low in our study. It might be due to different
factors: our patients’ younger age comparing other studies,
outpatient setting for recruitment, and lack of established fracture
liaison service.
Conclusion
This study showed no clinical beneﬁt for TBS in postmenopausal
women. Adding TBS data to aBMD or FRAX neither improved aBMD
predictive value for vertebral fracture nor changed the decision on
treatment based on FRAX.Sciences from ClinicalKey.com by Elsevier on September 08, 2019.
n. Copyright ©2019. Elsevier Inc. All rights reserved.
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